ABSTRACT Background
In autosomal dominant polycystic kidney disease (ADPKD), obtaining measured total kidney volume (mTKV) by magnetic resonance (MR) imaging and manual tracing is time consuming. Two alternative MR imaging methods have recently been proposed to estimate TKV (eTKV ellipsoid and eTKV PANK ), which require less time. We investigated if eTKV ellipsoid and eTKV PANK could be measured as reliable and reproducible as mTKV in patients with ADPKD.
Methods
For this study we included patients with ADPKD with a wide range of kidney function and an approved T2-weighted MR image. First, we investigated the reproducibility of mTKV and eTKV in a test-set of ADPKD patients. Second, we assessed bias, precision and accuracy of eTKV cross-sectionally in a cohort of ADPKD patients. Third, in a subgroup, we determined the association between change in mTKV and change in eTKV over time longitudinally.
Results
In the test set, intra-and intercoefficients of variation for mTKV, eTKV ellipsoid , and eTKV PANK were 1.8% and 2.3%, 3.9% and 6.3%, and 3.0% and 3.4%, respectively. In crosssectional analysis, baseline mTKV, eTKV ellipsoid , and eTKV PANK were 1.96 (IQR, 1.28-2.82), 1 .93 (IQR, 1.25-2.82), and 1.81 (IQR, 1.17-2.62) L, respectively. Bias was 0.02%±3.2%, 1.4%±9.2%, and 4.6%±7.6% for repeat mTKV, eTKV ellipsoid , and eTKV PANK , respectively. In longitudinal analysis, no significant differences were observed between percentage change in mTKV (16.7%±17.1%) and percentage change in eTKV ellipsoid (19.3%±16.1%) and eTKV PANK (17.8%±16.1%) over 3 years.
Conclusions
Both methods for eTKV perform relatively well compared to mTKV and can detect change in TKV over time. Because eTKV ellipsoid requires less time than eTKV PANK , we suggest that this method may be preferable in clinical care.
INTRODUCTION
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the formation and growth of numerous cysts in both kidneys, leading to an increase in kidney volume. These cysts compress healthy kidney tissue, causing progressive kidney function decline and, in most patients, ultimately a need for renal replacement therapy. In patients with ADPKD, total kidney volume (TKV) has been shown to be an early marker of disease severity and predictor of kidney function decline 1 .
Measurement of TKV is therefore used to assess prognosis in clinical care and for selection of patients for randomized controlled trials 2 . In these trials that investigate potential treatments for patients with ADPKD, assessment of TKV is often used as the primary or secondary study end point [3] [4] [5] .
The true gold-standard method to assess TKV is the manual tracing method. Computer tomogram or magnetic resonance (MR) images are used, and in each slice, the kidney boundaries are traced manually using dedicated software. Measured TKV (mTKV) is calculated from a set of contiguous images by summing the products of the area measurements within the kidney boundaries and slice thickness 6 . This method is laborious, which limits its use in trial settings, but especially in clinical care.
If kidney volume could be estimated with sufficient accuracy and reliability, it would alleviate the time-consuming process of kidney volume measurement. Recently, 2 kidney volume estimation methods have been developed: the midslice method 7 by the Consortium for Radiologic Imaging Studies of ADPKD (CRISP) and the ellipsoid method 2 by the Mayo Clinic. For both methods, measured and estimated kidney volumes appeared to be well correlated, but other groups have not yet validated these methods. In addition, the midslice method was developed in a cohort that included only patients with creatinine clearance 70 mL/min. In general, such patients have relatively small kidneys, making manual tracing measurement of TKV relatively easy, which may have influenced the results that were obtained. This method should therefore also be validated in patients with lower kidney function. Estimation methods to assess TKV may also be used in clinical trials, but only when they can accurately and reliably detect changes in TKV over time. To our knowledge, these issues have not been investigated to date.
24 Chapter 2 Given these considerations, the objective of the present study was to investigate cross-sectionally these methods to estimate TKV in a patient group with a wide range of kidney function. Furthermore, we investigated in a longitudinal study whether these estimation methods can accurately detect changes in TKV.
METHODS

Patients and study design
For this study, all MR images of patients with ADPKD that were available from 2007 through 2014 were used. These patients participated in 1 of 3 studies that were performed by the departments of nephrology at the University Medical Centers of Groningen, Leiden, Nijmegen, and Rotterdam (all in the Netherlands). Details of the study protocols have been published elsewhere 4, 8, 9 ; see Figure S1 for a flow diagram showing the assembly of the cohort. All patients were included if an MR image was available. ADPKD was diagnosed based on the modified Ravine criteria 10 . The Medical Ethics Committee of the University Medical Center Groningen approved the protocols of the 3 studies that were conducted in accordance with the International
Conference of Harmonization Good Clinical Practice Guidelines and in adherence to
the ethics principles that have their origin in the Declaration of Helsinki. All patients gave written informed consent.
Measurement and collections
All participants collected a 24-hour urine sample the day preceding the MR imaging (MRI), in which urinary albumin concentration was measured. At the outpatient clinic on the day of MRI, blood pressure was assessed at rest in a supine position with an automatic device (Dinamap; GE Medical Systems) for 15 minutes and weight and height were determined. Blood samples were drawn for determination of creatinine level with an enzymatic assay (isotope-dilution mass spectrometry traceable; Modular; Roche Diagnostics), which was used to estimate glomerular filtration rate (GFR) using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation 11 .
MR imaging
All participants underwent a standardized abdominal MRI protocol without the use of intravenous contrast. For the specific MRI protocol, see Item S1.
Gold-standard method: mTKV
Kidney and liver volumes were measured on the coronal fat saturated T2-single shot fast spin-echo sequence if possible. If the T2-weighted images showed too low quality, the MR image was excluded. Kidney and liver volumes were measured using the manual tracing method. Kidney and liver boundaries were manually traced using the commercially available software Analyze Direct 11.0 (Analyze Direct Inc). Kidney and liver volumes were calculated from the set of contiguous images by summing the products of the area measurements within the kidney or liver boundaries and slice thickness 6 . Nonrenal parenchyma (e.g. the renal hilus) was excluded from measurement.
Estimation methods: estimated TKV
The 2 formulas used to estimate kidney volume were derived from the literature 2, 7 .
We first used the midslice method to estimate TKV (eTKV PANK ) 7 . The midslices of the coronal MR images were selected for each kidney separately. The midslice was defined as the slice for which the slice number corresponds to half the sum of the numbers of the first and last slice that contained the kidney. If the sum was odd, the midslice number was rounded up. eTKV PANK was calculated in milliliters, with midslice area and slice thickness in millimeters squared and millimeters, respectively. eTKV PANK was calculated as the sum of the left eKV PANK (i.e., 0.624 * midslice area * number of slices covering the left kidney * slice thickness/1000) and right eKV PANK (i.e., 0.637 * midslice area * number of slices covering the right kidney * slice thickness/1000).
Second, we used the ellipsoid method to estimate TKV (eTKV ellipsoid ) 2 . For each kidney, length was measured as the average maximal longitudinal diameter measured in the coronal and sagittal plane. Width was obtained from the transversal image at maximum transversal diameter, and depth was measured from the same image perpendicular to the width measurement. eTKV ellipsoid was calculated in milliliters, with length, width, and depth all in millimeters. eTKV ellipsoid was calculated as the sum of the left KV ellipsoid and right KV ellipsoid , both derived by the equation π/6 * (length coronal + length sagittal )/2 * width * depth/1000. Of note, to assess eTKV ellipsoid , no specific software is necessary, in contrast to assessment of mTKV and eTKV PANK .
Statistical analyses
All analyses were performed with SPSS, version 22.0 (SPSS Inc). Normality of data was assessed by drawing Q-Q plots. Normally distributed variables are expressed as mean ± standard deviation, whereas non-normally distributed variables are given as median with interquartile range (IQR). Baseline characteristics of the study population are given overall (Table 1 ) and stratified for estimated GFR (eGFR) <60 and ≥60 ml/ min/1.73m 2 (Table S1) . Differences between groups were tested using a 2-sample t test for normally distributed and Mann-Whitney U test for non-normally distributed data. For paired analyses, a paired t test was used for normally distributed and a Wilcoxon signed rank test was used for non-normally distributed data. McNemar test was used for paired nominal data. A 2-sided p<0.05 was considered to indicate statistical significance. In a test set of 10 patients stratified for kidney volume and MRI scanner, kidney volumes were measured and estimated twice by 4 reviewers (MDAvG, JvM, BvS, JvE). All reviewers were blinded to their previous results. Reproducibility was evaluated by assessing intra-and intercoefficient of variation (CV) for mTKV, eTKV ellipsoid , and eTKV PANK . The inter-CV was calculated for each of the 10 MR images as the standard deviation of TKV values assessed by all 4 assessors divided by the mean TKV of that image multiplied by 100%. The inter-CV given in this study is the mean of the inter-CVs of these 10 MR images. Intra-CV was calculated per MR image for each of the 4 assessors as the standard deviation of TKV values divided by the mean TKV multiplied by 100%. Per assessor, an average intra-CV was calculated. The intra-CV given in this study is the mean intra-CV (plus standard deviation) of these 4 assessors. We used paired t test to compare CVs between mTKV and eTKV.
To investigate whether eTKV correlated with mTKV, orthogonal regression analysis was performed, and Lins' concordance correlation coefficient was calculated using all MRI scans of our cohort 12 . Orthogonal regression uses the least square data modeling technique in which observational errors in both dependent and independent variables are taken into account. Agreement between eTKV and mTKV was evaluated by Bland-Altman analyses, with calculation of agreement limits (95% confidence interval).
We used manual tracing as the gold standard for TKV measurement on the x-axis.
Performance of the estimation methods compared with mTKV was assessed using bias, precision, and accuracy. For cross-sectional analyses, bias is expressed as mean percentage difference ([mTKV -eTKV]/mTKV * 100%), with positive values indicating underestimation of mTKV. Precision was defined as 1 standard deviation of bias.
Accuracy was calculated as the percentage of eTKV values within 10%, 15%, and 20% of mTKV [P10, P15, and P20 respectively]). To investigate whether bias is dependent on patient or MR image characteristics, we performed regression analyses between bias and various variables; that is, age, length, body mass index, liver volume, and T1/T2-weighted images in univariate analyses. Differences in bias among the various scanners that were used were tested with analysis of variance. As standard quality control, ~10% of all MRI scans were measured twice for mTKV, and this is referred to as mTKV repeat . This was done to ensure that the observers maintained low interobserver variability. These scans were used to assess the precision and bias of mTKV.
To investigate whether the estimation methods can accurately detect changes in TKV, data for patients who had follow-up MR images available were used. For these longitudinal analyses, bias is expressed as the percent change in mTKV less the percent change in eTKV. Importantly, all follow-up scans were performed at the same MRI scanner as at baseline, and TKV was measured and estimated using the same series of images as at baseline, by reviewers blinded for baseline results.
To assess the consequences of using eTKV instead of mTKV, 2 analyses were performed.
First, the effect on classification based on disease prognosis was assessed. To assess prognosis for clinical care, a classification system is used that categorizes patients into 
RESULTS
Study participants
The study population consisted of 220 patients with ADPKD; their characteristics are listed in Table 1 . We excluded 44 patients because no T2-weighted images were available to perform both estimation methods. The patients were relatively young, with a mean age of 47.0 ± 8. 6 
Reproducibility of mTKV and eTKV
Performance of the TKV estimation methods
In the cohort for cross-sectional analyses, correlations of mTKV versus mTKV repeat , eTKV ellipsoid , and eTKV PANK are shown in Figure 1 . Figures S2 and S3 show these correlations for left and right kidneys, separately. High correlations were observed for all 3 methods (mTKV repeat : R= 0.998, p<0.001; eTKV ellipsoid : R=0.989, p<0.001; and eTKV PANK : R=0.990, p<0.001). Figure 1 also shows Bland-Altman plots of mTKV versus the percentage difference between mTKV and mTKV repeat and both eTKV methods. mTKV repeat showed low bias (mean, 0.02% ± 3.2%). eTKV also did not systematically over-or underestimate mTKV (bias of 1.4% ± 9.2% and 4.6% ± 7.6% for eTKV ellipsoid and eTKV PANK , respectively; Table 3 ). Bias for eTKV PANK was significantly higher than for mTKV repeat (p=0.005), whereas bias for eTKV ellipsoid did not significantly differ from that for mTKV repeat (p=0.4). Given the lower standard deviation, mTKV repeat had better precision and therefore better performance compared with eTKV ellipsoid and eTKV PANK .
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Chapter 2 In addition, when these analyses were repeated with patients with ADPKD stratified for eGFR, we observed no significant difference in bias for eTKV ellipsoid and mTKV repeat in patients with eGFRs <60 ml/min/1.73m 2 and eGFRs ≥60 ml/min/1.73m 2 (p=0.2 and p=0.3, respectively). Between eTKV PANK and mTKV repeat , we also observed no significant difference in patients with eGFR <60 ml/min/1.73m 2 (p= 0.2) and those with eGFR ≥60 ml/mn/1.73m 2 (p= 0.9). Table S2 shows bias and accuracy for eTKV stratified by eGFR.
When investigating factors associated with bias, it appeared that liver volume was associated with bias in eTKV PANK (p=0.04), but not with eTKV ellipsoid (p=0.1). Bias was not associated with age (p=0.5 and p=0.6), height (p=0.8 and p=0.1), or strength of magnetic field (p=0.8 and p=0.7), respectively, for eTKV ellipsoid and eTKV PANK . 
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Ability to detect changes in TKV when using estimation methods
Follow-up data for TKV were available for 48 patients. Baseline characteristics for the longitudinal cohort are given in Table 1 . These patients were younger, showed fewer signs of disease, and had higher eGFRs (79.7±22.6 mL/min/1. Median differences during follow-up were 0.25 (IQR, 0.04-0.54), 0.30 (IQR, 0.08-0.86), and 0.28 (IQR, 0.08-0.54) L for mTKV, eTKV ellipsoid , and eTKV PANK , respectively (Table   4 ). Change in eTKV compared to change in mTKV was not significantly different for both estimation methods (p=0.2 and p=0.5 for eTKV ellipsoid and eTKV PANK , respectively). of 22.2% ± 10.3% and 21.8% ± 8.3% for eTKV ellipsoid and eTKV PANK , respectively ( Figure   2 ). In most patients, bias for change in eTKV was between -10% and 10% (72.3% and 74.5% of patients for eTKV ellipsoid and eTKV PANK , respectively). 
Consequences of using eTKV instead of mTKV
When using eTKV methods instead of mTKV for risk classification with respect to prognosis for rapid kidney function decline, we excluded the radiologically atypical ADPKD cases (n=27), as advised for this classification system. There were 93.3%
(eTKV ellipsoid ) and 90.2% (eTKV PANK ) of patients reclassified to their original risk categories ( (Table 5 ). 
DISCUSSION
This study was conducted to investigate whether TKV can be estimated accurately using the midslice (PANK) and ellipsoid methods in a group of patients with ADPKD with a wide range of kidney function. In a test set of 10 patients with ADPKD, we found that both estimation methods were highly reproducible. In our study cohort of 220 patients with ADPKD, both methods showed low bias, high precision, and high accuracy when compared to mTKV. This held for the overall cohort, as well as for patients with higher and lower eGFRs. In the 48 patients who had follow-up MR images available, change in eTKV was not different from change in mTKV for both methods.
Assessment of TKV using the gold-standard method of manual tracing is time consuming and needs specific software, which limits its applicability for clinical care. Methods have therefore been sought to estimate TKV in a more feasible way. Two methods have been published recently 2, 7 ; however, they have not been validated to date. This formed the rationale to perform the present study. For determination of whether these estimation methods can be used to assess TKV, it is important to answer the following 5 questions.
First, it is important to investigate what the reliability of the gold-standard method is.
In our study, we found that the variability in volumetric assessment by manual tracing was very low. In general, T1-instead of T2-weighted images are used for volumetry in ADPKD because researchers want to align with the original CRISP methodology.
However, when the CRISP Study started, gadolinium-enhanced T1-weighted MR images were used. Because of the potential adverse effects of gadolinium, use of this contrast agent has since been discouraged. Bae et al 14 showed in 2009 that unenhanced T1-weighted volumes were significantly lower than contrast enhanced T1-weighted volumes. These differences were more pronounced in smaller kidneys because in such cases, the ratio of kidney boundaries area to kidney volume is higher. Bae et al 14 mentioned that one should therefore contemplate using T2 MRI for quantification of TKV because the high kidney tissue contrast and hyperintense renal cysts in T2 images aid in delineating kidney boundaries against background tissues when compared to T1-weighted images. At that time, T2-weighted imaging required longer scanning time and was subjected to increased variation in image quality because of motion artefacts and was therefore not feasible. Nowadays, T2-weighted scanning time is shorter and respiratory triggering to avoid motion artefacts has become available. In our experience, this sequence has the best quality in visualizing polycystic kidneys.
We therefore chose T2-weighted images instead of T1-weighted images for our study.
Second, do these estimation methods show low variability? Variability in mTKV versus eTKV PANK was not significantly different and satisfactorily low. Variability in eTKV ellipsoid was significantly higher compared to mTKV, meaning that this method is slightly more operator dependent than the midslice method, but still low. In line with this, reclassification to another risk category for rapid kidney function decline for clinical care (Irazabal classes A-E 2 ) happened infrequently when using eTKV PANK , as well as eTKV ellipsoid (Table 5 ). Given these results and because eTKV ellipsoid is more convenient (shorter duration per MR image and assessment possible using standard MRI software),
we advise that eTKV ellipsoid be used rather than eTKV PANK for risk assessment in clinical care.
Third, does the estimation method show good agreement with the gold-standard method? We found for both estimation methods that eTKV correlated strongly with mTKV. Although bias and precision again showed better values for mTKV repeat (0.02% and 3.2%, respectively), results for eTKV ellipsoid and eTKV PANK were good. Bias was low for eTKV ellipsoid and eTKV PANK (1.4% and 4.6%, respectively), although for eTKV PANK , it was slightly (but significantly) higher than for mTKV repeat . In addition, precision was reasonable, now with slightly better results for eTKV ellipsoid (eTKV ellipsoid and eTKV PANK :
9.2% and 7.6%, respectively; Table 3 ). Consequently, we found good accuracy for both estimation methods (P 20 for eTKV PANK and eTKV ellipsoid of 96.4% and 97.7%, respectively).
Our findings with respect to accuracy are consistent with values obtained in the cohort in which the ellipsoid method was developed (P 10 of 70.3% vs. 78.1% in the present study) 2 . When stratified for kidney function, our results with respect to bias suggest that the midslice method may be less accurate in patients with ADPKD with lower kidney function, who generally have larger kidneys. Besides these statistical data, consequences for clinical care should be investigated when answering the question of whether estimation methods show good agreement with the gold-standard method.
Irazabal et al 2 proposed a classification system for patients with ADPKD to assess their risk for rapid kidney function decline and to guide selection of patients for clinical trials. This classification system uses thresholds defined by age-and height-corrected TKV. We investigated the percentage of patients who are reclassified when using eTKV instead of mTKV. In the classification system for risk assessment, we observed that only a limited percentage of patients were reclassified, and these patients were most likely to be reclassified to a lower risk category (Table 5 ). No fundamental differences in results were observed for the 2 TKV estimation methods, and only one patient was reclassified when using eTKV PANK to a risk category that would preclude treatment (category B).
Fourth, can the estimation method detect changes in TKV over time? As far as we are aware, no study has yet investigated the performance of estimation methods to assess changes in TKV. In our analyses, we found a high concordance correlation between change in mTKV and change in eTKV PANK and eTKV ellipsoid during 3 years of follow-up, and no difference between change in mTKV and change in eTKV PANK and eTKV ellipsoid (Table 5 ). Consequently, when data for change in eTKV instead of change in mTKV are used, similar numbers of patients have to be included in clinical trials to be able to show a decrease in rate of growth in TKV (Table 5 ). These longitudinal results may seem surprising because they appear to be in contrast to our cross-sectional data,
in which we showed that mTKV shows better reliability than eTKV PANK and eTKV ellipsoid , albeit these differences were small. In our opinion, this may have 2 explanations. It could be that with eTKV methods, a systematic error is made in an individual patient in assessing TKV at baseline, for instance, due to a peculiar shape of a cystic kidney, but that the same error is made during follow-up because the shape of the cystic kidney has not changed. In this way, a systematic error in baseline eTKV will not translate in bias in change in eTKV during follow-up on a patient level. In addition, the natural variability in growth in TKV between patients may be so high that the limited variability that is added by using eTKV is not relevant when assessing mean change in TKV on a group level.
The fifth and last question to be answered is whether the estimation method is feasible from a clinical point of view. To estimate TKV using the midslice method, special software is necessary to measure the midslice area, limiting clinical applicability. In contrast, all clinicians can estimate TKV by the ellipsoid method using standard MR images without special software. Furthermore, the ellipsoid method requires less time to estimate TKV than using the midslice method, and both methods require far less time than assessment of mTKV with the gold standard method of manual tracing.
The answers to these questions indicate that although eTKV may be slightly less precise than mTKV using the manual tracing method, it can be used with confidence in clinical care. Because numerically the 2 eTKV methods show hardly any differences with respect to bias, precision, and accuracy and no difference in ability to detect changes in eTKV, the more feasible ellipsoid method is to be preferred over the midslice method. Whether this conclusion is also valid for the use of eTKV ellipsoid instead of mTKV for clinical trials needs confirmation. To investigate this issue, results of these 2 assessment techniques should be compared in large-scale trials between different intervention groups using MR images obtained at baseline and during follow-up. Our data form the rationale to perform such studies.
A limitation of the present study is that our results hold primarily true for the crosssectional correlation between mTKV and eTKV. Our results for follow-up data should be interpreted with caution because results are based on a limited number of patients.
Strengths of this study are that we investigated both estimation methods in a group of patients with ADPKD with relatively well-preserved as well as reduced kidney function, and we are apparently the first to externally validate both estimation methods.
In conclusion, we demonstrated that both methods to estimate TKV perform relatively well in patients with ADPKD overall, and in patients with preserved as well as reduced kidney function. In addition, both estimation methods detect relatively accurate changes in TKV over time. Because of these results and the higher feasibility of the ellipsoid method, we advise that the ellipsoid method be used for TKV estimation in clinical care. Whether this method can also be used for clinical trials deserves further study.
SUPPLEMENTARY METHODS
Magnetic resonance imaging
The UMC Groningen used a 1. Abbreviations and definitions are: eTK V ellipsoid , estimated total kidney volume using ellipsoid method; eTKV PANK , estimated total kidney volume using mid-slice method; eGFR, estimated glomerular filtration rate. Accuracy, percentage of estimated total kidney volume values within 10% (P 10 ), 15% (P 15 ) and 20% (P 20 ) of their corresponding measured total kidney volume value (TKV). Bias, mean % difference between mTKV and eTKV. Precision, 1 standard deviation of bias; CCC, concordance correlation coefficient. P values for eTKV ellipsoid ≥60 vs. <60 are calculated by t test when normally distributed and Mann-Whitney U test when non-normally distributed. Table S3 . Number of participants per treatment group needed for randomized controlled trials to be able to show a specific % difference in growth in total kidney volume over a period of three years when using gold standard total kidney volume (mTKV) or estimated kidney volume using the ellipsoid method (eTKV ellipsoid ) or mid-slice method (eTKV PANK ). 
